Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Supplementation of Galatonol 300 mg / Striatin 30 mg Combined Bioactive Fraction in Postpartum Lactating Mothers

NCT06558071 is registered in ClinicalTrials.gov with Dexa Medica Group as lead sponsor.

NCT NCT06558071
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06558071 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Supplementation of Galatonol 300 mg / Striatin 30 mg Combined Bioactive Fraction in Postpartum Lactating Mothers
Lead sponsor
Dexa Medica Group
Phase
Phase 3
Overall status
Completed
Start date
October 21, 2024
Completion date
May 27, 2025
Enrollment
160 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

lactation induced